A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model

The programmed cell death 1 (PD-1) pathway represents a major immune checkpoint which may be engaged by cells in a tumor microenvironment to overcome active T-cell immune surveillance. Pembrolizumab (Keytruda®) is a potent and highly selective humanized monoclonal antibody (mAb) of the IgG4/κ isotyp...

Full description

Bibliographic Details

Published in:	Journal of Immunotoxicology
Main Authors:	Lisa M. Plitnick, Beth Hutchins, Sheri Dubey, Nianyu Li, Rupesh P. Amin, Stephanie Born, Ruban Mangadu, Joseph H. Phillips, Venkataraman Sriram, Danuta J. Herzyk
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Subjects:	anti-pd-1 vaccination murine alternate model
Online Access:	http://dx.doi.org/10.1080/1547691X.2020.1826020